Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feilike Mixture Safety Registry in Minors
ChiCTR2100052084Phase 4Not yet recruiting
- Sponsor
- Leshan People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Feilike Heji in asthma and bronchitis, sponsored by Leshan People's Hospital. Primary endpoint: Adverse events. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
Feilike Heji
03
Conditions
asthmabronchitis
Beyond the preview
Go deeper on ChiCTR2100052084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052084.